GLAXOSMITHKLINE BIOLOGICALS S.A.;GLAXO GROUP LIMITED
发明人:
BROWN, JAMES,METTENS, PASCAL,MURPHY, DENNIS
申请号:
CA2731549
公开号:
CA2731549C
申请日:
2009.07.24
申请国别(地区):
CA
年份:
2018
代理人:
摘要:
The present invention is directed to a polypeptide which comprises: (i) anRv1753c protein sequence; (ii) a variantof an Rv1753c protein sequence; or (iii) an immunogenic fragment of an Rv1753cprotein sequence. In other aspects the inventionis directed to associated polynucleotides, fusion proteins and methods for thetreatment or prevention of tuberculosis.